An interventional study of Digital Blood Pressure Monitoring System and Mobile health application in Hypertension in Pregnancy, Pre-Eclampsia and Eclampsia, sponsored by Northwestern University. Active, not recruiting at 1 site in United States. Open to female participants aged 18 Years to 99 Years. Per ClinicalTrials.gov, last updated 2026-06-08.
Sponsored by Northwestern University · Not applicable, Interventional, and Prevention
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 106 studies in Hypertension, Pregnancy-Induced with a site in United States — 30 open to participants now, 40 under way, 4 of them phase 3. Hypertension, Pregnancy-Induced · United States.
Among the 106 studies in Hypertension, Pregnancy-Induced with a site in United States, this one is the 44th largest by planned enrollment of the 89 interventional ones that give a count, is one of 13 that started in 2024, is one of 51 with no phase, reaches primary completion later than 10 of the 39 other live ones, and was the 84th registered.
262 studies on the registry are indexed under Hypertension, Pregnancy-Induced; 70 are open to participants now.
Browse Hypertension, Pregnancy-Induced studies →30 of the 106 studies in Hypertension, Pregnancy-Induced with a site in United States are open now. Recruiting first, the newest first:
University of Alabama at Birmingham · Sites in United States
Ages 16–56 · Women only
Texas Southern University · Sites in United States
Ages 18–45 · Women only
Wake Forest University Health Sciences · Sites in United States
Ages 18–45 · Women only
Massachusetts General Hospital · Sites in United States
Ages 18–65 · Women only
Jennifer Lewey, MD, MPH · Sites in United States
Ages 18+ · Women only
A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →
Of the 53 Hypertension, Pregnancy-Induced studies recruiting now, 23 (43%) set no upper age limit and 29 (55%) stop at 75 or younger; 7 take children under 18; 16 take healthy volunteers.
This study: 18 Years to 99 Years · female · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
106 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 4 · Phase 2 8 · Phase 3 10 · Phase 4 18
First in 2001; this study’s year is marked. 13 started in 2024.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 120 is below the median of 147 across 174 interventional studies indexed under Hypertension, Pregnancy-Induced.
Median enrollment 120 across the 89 interventional studies, 120 across the 17 observational. Of the 55 that completed or were terminated, 33 (60%) have results posted.
This tab as a report to print or save as PDF → With an account.
1 of 106 have an industry lead sponsor. The 10 most frequent:
Northwestern University is the lead sponsor of 1,424 studies on the registry; 199 are open to participants now.
Of its 105 completed or terminated interventional studies of FDA-regulated products, 78 (74%) have results posted.
Northwestern University has 4 studies filed under Hypertension, Pregnancy-Induced — fewer than ten, so there is no comparison to draw.
14 of the studies in Hypertension, Pregnancy-Induced with a site in United States that are under way reach primary completion within a year, 1 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07222852Phase 3Women and Infants Hospital of Rhode IslandCardiovascular Protection After Preeclampsia With Enalapril | 2027-10-15 |
| NCT07356518Wake Forest University Health SciencesTelehealth and Remote Blood Pressure | 2026-12 |
| NCT05676476University of Alabama at BirminghamThe ACHIEVE Trial: Achieving Longer Gestation in Preeclampsia Via Antihypertensive Therapy. | 2026-12 |
| NCT06523569Northwestern UniversityMobile Health Interventions to Prevent Heart Disease After Hypertensive Disorders of Pregnancy | 2026-12-01 |
| NCT05989581University of Alabama at BirminghamChronic Hypertension and Pregnancy 2 (CHAP2) Pilot Project | 2026-12-31 |
Add all 14 to your calendar (.ics) → With an account.
Among the 106 studies in Hypertension, Pregnancy-Induced with a site in United States, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The purpose of this research is to study digital health interventions to prevent cardiovascular disease in individuals who have had a hypertensive disorder of pregnancy (HDP).
The purpose of this research is to test the effect of two digital health interventions on cardiovascular health and subclinical cardiac dysfunction in postpartum individuals after pregnancies complicated by new-onset hypertensive disorder of pregnancy (HDP). All participants will undergo echocardiography and have their blood pressure/weight captured at 3 months and 12 months postpartum. If randomized to the intervention arm, the participant will be given a subscription to a mobile health application and a digital blood pressure monitoring system, and asked to utilize these at home during the one year of the study along with usual care. If randomized to the control arm, the participant will receive care as usual.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
BMI (body mass index)
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Participant will receive usual care.
Participant will be enrolled in a digital blood pressure monitoring program and receive a subscription to a mobile health lifestyle change application (Noom) alongside usual care.
Other: Digital Blood Pressure Monitoring System · Other: Mobile health application
As a part of the bundled digital health intervention, the participant will receive instructions on how to follow a link in their electronic patient portal that will allow direct input of home blood pressure readings for clinical review.
As a part of the bundled digital health intervention, the participant will be given a lifestyle change mobile health application.
Systolic blood pressure
All participants will have systolic blood pressure measured at 3 months and 12 months postpartum
Time frame: 3 months postpartum; 12 months postpartum
Weight
All participants will have weight measured at 3 months and 12 months postpartum
Time frame: 3 months postpartum; 12 months postpartum
Subclinical cardiovascular dysfunction via echocardiography
All participants will have echocardiography performed at 3 months and 12 months postpartum to assess subclinical cardiovascular dysfunction
Time frame: 3 months postpartum; 12 months postpartum
Study feasibility
The investigators will assess study feasibility (% enrolled in digital health intervention) at the end of the study
Time frame: 12 months postpartum
Participant engagement
The investigators will assess participant engagement (% continuing to actively use digital health interventions) at the end of the study
Time frame: 12 months postpartum
Anti-hypertensive medication use (%)
The investigators will assess participant anti-hypertensive medication use (%) at 3 months and 12 months
Time frame: 3 months postpartum; 12 months postpartum
Plan to share: No
No publications or documents are linked to this record.
Started Nov 2024 (actual). Primary completion is estimated for Dec 2026, 24 months after the start.
Of 91 non-industry interventional studies with no phase under Hypertension, Pregnancy-Induced, half reached primary completion within 24 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 34. This study's planned 24 months is close to that.
Counting every sponsor, half of 92 studies reached it within 24 months; a quarter within 10 and three quarters within 34.
How these figures are worked out, and which studies are left out of them.
This study is active, not recruiting, as verified in Jun 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Hypertension, Pregnancy-Induced →